Finance

Lists
4577:TYO
Daito Pharmaceutical Co Ltd
¥1,356.00
-1.09%
(-15.00) 1D
Oct 19, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4577...
Open
¥1,378
High
¥1,382
Low
¥1,348
Mkt. cap
39.13B
Avg. vol.
78.01K
Volume
84.20K
Dividend
2.95%
Quarterly dividend
¥10
Ex-dividend date
Nov 27, 2026
P/E ratio
12.42
52-wk high
¥1,521
52-wk low
¥1,120
EPS
¥109
Shares outstanding
12.51M
No. of employees
1K
Open
¥1,378
High
¥1,382
Low
¥1,348
Mkt. cap
39.13B
Avg. vol.
78.01K
Volume
84.20K
Dividend
2.95%
Quarterly dividend
¥10
Ex-dividend date
Nov 27, 2026
P/E ratio
12.42
52-wk high
¥1,521
52-wk low
¥1,120
EPS
¥109
Shares outstanding
12.51M
No. of employees
1K
News stories
From web sources and news partners
About Daito Pharmaceutical Co Ltd
CEO-
Employees1.08K
FoundedJun 30, 1942
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Nov 2025
Feb 2026
May 2026
Aug 2026
Revenue
12.13B
11.59B
13.92B
11.89B
Cost of goods sold
9.92B
9.24B
11.14B
9.70B
Cost of revenue
9.92B
9.24B
11.14B
9.70B
Research and development expenses
-
-
2.22B
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.58B
1.23B
-327.00M
1.48B
Operating expense
1.58B
1.23B
1.90B
1.48B
Total operating expenses
11.50B
10.46B
13.03B
11.18B
Operating income
627.00M
1.13B
884.00M
713.00M
Other non operating income
102.00M
-1.00M
30.00M
9.00M
EBT including unusual items
782.00M
1.44B
796.00M
962.00M
EBT excluding unusual items
789.00M
1.21B
917.00M
807.00M
Income tax expense
237.00M
387.00M
-71.00M
245.00M
Effective tax rate
30.31%
26.97%
-8.92%
25.47%
Other operating expenses
-
-
-
-
Net income
537.00M
1.03B
894.00M
700.00M
Net profit margin
4.43%
8.92%
6.42%
5.89%
Earnings per share
-
-
-
-
Interest and investment income
7.00M
29.00M
-
38.00M
Interest expense
-33.00M
-33.00M
-34.00M
-30.00M
Net interest expenses
-26.00M
-4.00M
-34.00M
8.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.69B
2.21B
1.98B
1.81B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps